cetuximab,GDC-6036,Atezolizumab,Bevacizumab,Erlotinib,GDC-1971,Inavolisib
eli lilly,roche
['gdc-6036', 'cetuximab']
really amazing data on gdc-6036 plus cetuximab in kras g12c metastatic colon cancer - orr 62% !!! more potent kras g12c inhibitors make for more effective combos &amp; better options for patients. #aacr23 
Lung oncologist, tumor immunology & KRAS researcher, advocate for lung cancer patients and learners @pmcancercentre, @uoftmedicine, @UofT. He/Him/Il. 🏳️‍🌈